Plant Produced Biosimilars

 

<p justify;"="" style="text-align: justify;">Biosimilar products are also produced from plants. Plants are the richest store house of diverse class of phytochemicals. Production of Biosimilar products in tobacco plants is on the verge of completion of the first step in their research. These also includes Transgenic plants, Post translational genetics, Fermentation culture, Molecular farming. For biosimilar manufacturers this session has the potential to bring up new avenues in their product range. Pharmacognosy researchers would find this track highly interesting and informative towards their research work. Proportion of plant produced Biosimilars are comparably low. However, an increased level of plant sourced Biologics ~25% is owned to be seen in the market. Especially Biologics derived from the plant sources are expected to occupy about more than 20% of all Biologics.

  • Transgenic plants
  • Post translational genetics
  • Fermentation culture
  • Molecular farming

Related Conference of Plant Produced Biosimilars

February 28-March 01, 2019

Global Pharmaceutical and Pharma Industry Conference

Osaka, Japan
March 18-20, 2019

18th World Pharma Congress

Edinburgh, Scotland
March 18-19, 2019

13th International Conference on Biosimilars and Biologics

Amsterdam | Netherlands
July 26-27, 2019

13th Asian Biologics and Biosimilars Congress

Melbourne, Australia

Plant Produced Biosimilars Conference Speakers

Recommended Sessions

Related Journals

Are you interested in